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Abstract Impaired scavenger receptor class B type I (SR-BI)-
mediated uptake ofHDL-cholesterol esters (HDL-CE) induces
adrenal insufficiency in mice. Humans contain an alternative
route of HDL-CE clearance, namely through the transfer by
cholesteryl ester transfer protein (CETP) to apolipoprotein
B lipoproteins for subsequent uptake via the LDL receptor.
In this study, we determined whether CETP can compensate
for loss of adrenal SR-BI. Transgenic expression of human
CETP (CETP Tg) in SR-BI knockout (KO) mice increased
adrenalHDL-CE clearance from33–58%of the control value.
SR-BI KO/CETP Tg and SR-BI KO mice displayed adrenal
hypertrophy due to equally high plasma adrenocorticotropic
hormone levels. Adrenal cholesterol levels and plasma corti-
costerone levels were 38–52% decreased in SR-BI KO mice
with andwithout CETP expression. SR-BI KO/CETPTgmice
also failed to increase their corticosterone level after lipo-
polysaccharide challenge, leading to an identical .4-fold in-
creased tumor necrosis factor-a response compared with
controls. These data indicate that uptake of CE via other
routes than SR-BI is not sufficient to generate the cholesterol
pool needed for optimal adrenal steroidogenesis. In conclu-
sion, we have shown that CETP-mediated transfer ofHDL-CE
is not able to reverse adrenal insufficiency in SR-BI knockout
mice. Thus, SR-BI-mediated uptake of serum cholesterol is
essential for optimal adrenal function.—Hoekstra, M., D. Ye,
R. B. Hildebrand, Y. Zhao, B. Lammers, M. Stitzinger, J.
Kuiper, T. J. C. Van Berkel, and M. Van Eck. Scavenger recep-
tor class B type I-mediated uptake of serum cholesterol is es-
sential for optimal adrenal glucocor ticoid production.
J. Lipid Res. 2009. 50: 1039–1046.
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HDL is a small, dense protein-lipid complex that consists
of a hydrophilic phospholipidmonolayer and a hydrophobic
core filled with cholesteryl esters. The HDL-mediated trans-
port of cholesterol from peripheral tissues back to the liver
for subsequent excretion from the body, often referred to
as reverse cholesterol transport [reviewed in Van Eck et al.
(1) and Lewis and Rader (2)], is considered to be an impor-
tant physiological process tomaintain total body cholesterol
homeostasis. Scavenger receptor class B type I (SR-BI) is a
multiligand cell surface receptor predominantly expressed
in the liver and steroidogenic tissues (i.e., testis, ovary, and
adrenals) (3). In mice, SR-BI is a prominent factor in the
reverse cholesterol transport process, as it is the sole mole-
cule involved in the selective uptake of cholesteryl esters
from HDL by the liver (4). In addition to its established
function in liver cholesterol metabolism, we (5) and others
(6) have recently shown that SR-BI also plays a major
role in adrenal cholesterol metabolism and steroid hor-
mone production in mice. As a result, SR-BI deficiency in
mice is associated with a depletion of adrenal cholesterol
stores, resulting in a diminished steroid hormone (i.e., gluco-
corticoid) production in response to physiological stress.
Importantly, the metabolism of HDL differs significantly
between humans and mice as humans, in contrast to ro-
dents, naturally express cholesteryl ester transfer protein
(CETP). CETP is synthesized by macrophage-rich tissues,
such as the spleen and liver, after which it is secreted into
the blood circulation (7–10). In plasma, CETP is able to
transfer cholesteryl esters from HDL to apolipoprotein B
(ApoB)-containing particles, such as VLDLs and LDLs.
LDL-associated cholesteryl esters can subsequently be
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cleared from the blood circulation via whole particle uptake
by the LDL receptor (ApoB receptor) (11, 12). In addi-
tion to SR-BI, the CETP→LDL→LDL receptor pathway
can thus serve as an alternative route for the delivery of
HDL-cholesteryl esters to cells in humans. However, the rel-
ative contribution of the SR-BI and the CETP→LDL→LDL
receptor routes for the uptake of HDL-cholesteryl esters in
humans is still unclear because polymorphisms in the hu-
man SR-BI gene leading to functional SR-BI deficiency so
far have not been detected.
In vitro studies using adrenocortical cells have suggested
that LDL receptor-mediated uptake of LDL is coupled to
steroid hormone synthesis (13). In addition, Kita et al.
(14) and Fong et al. (15) have shown that the adrenals ex-
press a functional LDL receptor in vivo. It is thus likely that
theCETP→LDL→LDL receptor route is relevant for adrenal
cholesterol homeostasis in the human situation. To gain in-
sight in the possible role for theCETP→LDL→LDL receptor
route in adrenal cholesterol metabolism, we have deter-
mined whether transgenic expression of human CETP
can rescue the adrenal glucocorticoid insufficiency in SR-BI
knockout (KO) mice.
MATERIALS AND METHODS
Animals
SR-BI KO mice were kindly provided by Dr. M. Krieger (Massa-
chusetts Institute of Technology, Boston, MA) (16). CETP trans-
genicmice (CETPTg; strain 5203) expressing humanCETP under
the control of its own promoter and other major regulatory ele-
ments were obtained from The Jackson Laboratory (Bar Harbor,
ME) (17). SR-BI KO mice were bred with CETP Tg mice to gen-
erate heterozygous SR-BI KO mice expressing CETP on one
allele. These mice were subsequently cross-bred to generate SR-
BI KO mice expressing human CETP on one allele (SR-BI KO/
CETP Tg) or control SR-BI KO mice and wild-type (WT) non-
transgenic littermates. The presence of the targeted and wild-
type SR-BI alleles as well as the CETP transgene was assessed
by PCR amplification of DNA extracted from tail biopsies (prim-
ers: 5′ -GATGGGACATGGGACACGAAGCCATTCT-3′ and
5′-TCTGTCTCCGTCTCCTTCAGGTCCTGA-3′ for SR-BI and
5′ -CTAGGCCACAGAATTGAAAGATCT-3′ , 5′ -GTAGGTG-
GAAATTCTAGCATCATCC-3 ′ , 5 ′ -GAATGTCTCAGAG-
GACCTCCC-3′, and 5′-CTTGAACTCGTCTCCCATYCAG-3′ for
CETP). Mice were fed a sterilized regular chow powder diet (RM3;
Special Diet Services, Witham, UK). Animal experiments were per-
formed at the Gorlaeus Laboratories of the Leiden/Amsterdam
Center for Drug Research in accordance with the national laws.
All experimental protocols were approved by the Ethics Commit-
tee for Animal Experiments of the Leiden University.
Analysis of gene expression by real-time quantitative PCR
Quantitative gene expression analysis on snap-frozen organs
was performed as described (18). In short, total RNAwas isolated
according to Chomczynski and Sacchi (19) and reverse transcribed
using RevertAid™ reverse transcriptase. Gene expression analysis
was performed using real-time SYBRGreen technology (Eurogentec)
with the primers displayed in Table 1, which were validated for iden-
tical efficiencies (slope523.3 for a plot of threshold cycle number
(Ct) versus log ng cDNA). Hypoxanthine guanine phosphoribosyl
transferase (HPRT), GAPDH, and acidic ribosomal phosphopro-
tein P0 (36B4) were used as the standard housekeeping genes. Rel-
ative gene expression numbers were calculated by subtracting the
Ct of the target gene from the average Ct of HPRT, GAPDH, and
36B4 (Ct housekeeping) and raising 2 to the power of this difference.
Genes that exhibited a Ct value of.35 were considered not detect-
able. The average Ct of three housekeeping genes was used to ex-
clude that changes in the relative expression were caused by
variations in the expression of the separate housekeeping genes.
Isolation and labeling of HDL
Human HDL was isolated from blood of healthy subjects by dif-
ferential ultracentrifugation as described by Redgrave, Roberts,
and West (20) and dialyzed against PBS with 1 mM EDTA. HDL
(1.063 , d , 1.21) was labeled with [3H]cholesteryl ether (CEt)
via exchange from donor particles as reported previously (21).
Adrenal uptake of 3H-Cholesteryl ether HDL
A dose of 200 mg apolipoprotein (61.2 3 106 dpm) of [3H]
CEt-HDL (total volume 100 ml) was injected into the tail vein.
At 5 min after injection, a blood sample was drawn to verify the in-
jected dose. For analysis of adrenal cholesteryl ether uptake, 24 h
after tracer injection adrenals were excised, weighed, solubilized,
and counted for 3H-radioactivity in a Packard liquid scintillation
unit. A correctionwasmade for the radioactivity in thebloodpresent
in the adrenals at the time of sampling (135.2 ml/g tissue).
Lipoprotein distribution analysis
The distribution of cholesterol or 3H-label over the different
lipoproteins in plasma was analyzed by fractionation of pooled
plasma using a Superose 6 column (3.2 3 300 mm, Smart-system;
Pharmacia). Total cholesterol content of the effluent was deter-
mined using enzymatic colorimetric assays (Roche Diagnostics).
Counting for 3H-radioactivity was performed in a Packard liquid
scintillation unit.
Adrenal histology and immunohistochemical analysis
for CETP
Formalin-fixed cryosections (8–10 mM) were prepared on a
Leica CM3050-S cryostat. Cryosections were routinely stained with
hematoxylin and Oil red O for nuclei and neutral lipids, respec-
tively. For immunohistochemical staining of CETP, cryostat sec-
tions were incubated for 5 min with prewarmed (37°C) 0.025%
trypsin at room temperature, blocked with 1% BSA in TBS, and
TABLE 1. Primers used for real-time PCR analysis
GenBank Accession
Number Forward Primer Reverse Primer
36B4 X15267 GGACCCGAGAAGACCTCCTT GCACATCACTCAGAATTTCAATGG
HPRT J00423 TTGCTCGAGATGTCATGAAGGA AGCAGGTCAGCAAAGAACTTATAG
GAPDH NM008084 TCCATGACAACTTTGGCATTG TCACGCCACAGCTTTCCA
CETP NM000078 CAGATCAGCCACTTGTCCAT CAGCTGTGTGTTGATCTGGA
LDL receptor Z19521 CTGTGGGCTCCATAGGCTATCT GCGGTCCAGGGTCATCTTC
SR-BI NM016741 GGCTGCTGTTTGCTGCG GCTGCTTGATGAGGGAGGG
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incubated with a primary CETP antibody TP-2 (Ottawa Heart In-
stitute, Ontario, Canada) and a secondary antibody conjugated to
peroxidase (Jackson ImmunoResearch Labs, Suffolk, UK).
Images were obtained with a Leica image analysis system, consist-
ing of a Leica DMRE microscope coupled to a camera and Leica
Qwin Imaging software (Cambridge, UK).
Plasma hormone analysis
Blood was drawn via the tail vein between 0900 and 1200 h for
subsequent hormone analyses. Corticosterone and adrenocorti-
cotropic hormone (ACTH) levels in plasma were determined
using the CORTICOSTERONE and ACTH Double Antibody
125I Radioimmunoassay (RIA) kits from MP Biomedicals (Irvine,
CA) according to the protocols from the supplier.
Tumor necrosis factor-a response upon
lipopolysaccharide challenge
Mice were intravenously injected at 0900 h with 50 mg/kg LPS
from Salmonella minnesota R595 (List Biological Laboratories,
Hornby, Canada) into the tail vein. Blood samples were collected
after 30, 60, 90, 120, and 180min, and plasma tumor necrosis factor-a
(TNF-a) protein levels were determined by ELISA (OptEIA kit;
BD Biosciences Pharmingen, San Diego, CA).
Data analysis
Data were presented as means 6 SEM. Statistical analyses were
performed using one- and two-way ANOVA using Graphpad
Prism Software (Graphpad Software, San Diego, CA). The level
of statistical significance was set at P , 0.05.
RESULTS
In this study, we determined whether the CETP→
LDL→LDL receptor route may be physiologically relevant
for adrenal cholesterol metabolism and steroid hormone
production. For this purpose, we cross-bred mice carrying
the human CETP transgene linked to its natural flanking
sequences (CETP Tg) with SR-BI KO mice to generate
“human-like” SR-BI KO mice carrying the CETP transgene
(SR-BI KO/CETP Tg mice). SR-BI KO/CETP Tg mice, like
control SR-BI KO mice, lack a functional SR-BI gene, as
evident from the undetectable mRNA expression of SR-BI in
liver, spleen, adrenals, and white adipose tissue (Table 2).
However, in contrast with control SR-BI KO mice, SR-BI
KO/CETP Tg mice express relatively high levels of human
CETP mRNA in macrophage-rich tissues, such as the liver
and spleen, similarly as found in the human situation (8).
To investigate whether CETP expression in SR-BI KO
mice induces transfer of cholesteryl esters from HDL to
ApoB-containing lipoproteins for subsequent uptake by
the LDL receptor in the adrenals, we determined the effect
of transgenic expression of human CETP on plasma total
cholesterol levels and the adrenal HDL-cholesteryl ester up-
take in SR-BI KO mice. As shown in Fig. 1A, transgenic ex-
pression of human CETP induced an almost complete
normalization of plasma total cholesterol levels in SR-BI
KO mice, indicating that the CETP-mediated transfer of
cholesteryl esters from HDL to VLDL/LDL fraction can
also act as an effective alternative pathway to remove choles-
teryl esters from the blood circulation in SR-BI KOmice. In
parallel to the observed change in plasma cholesterol levels,
the uptake of [3H]CEt-HDL by the adrenals was also partially
restored in SR-BI KO/CETP Tg mice compared with SR-BI
KOmice [206 1% vs. 116 1% of the injected dose/g tissue
(P , 0.05), respectively, compared with 34 6 3% for wild-
type mice; Fig. 1B]. CETP-mediated transfer of cholesteryl
esters fromHDL to ApoB-containing lipoproteins thus does
significantly increase the adrenal uptake ofHDL-cholesteryl
esters in SR-BI KO mice probably via the action of the LDL
receptor. Evaluation of the [3H]CEt distribution over the dif-
ferent lipoprotein fractions at 8 h after [3H]CEt-HDL injec-
tion showed that 4.2-fold more of the [3H]label resided in
the nonHDL fraction permg cholesterol in SR-BI KO/CETP
Tg mice compared with SR-BI KO mice, while a 30% lower
amount of [3H]label per mg cholesterol was detected in the
HDL fraction (Fig. 1C), resulting in an overall 6-fold higher
nonHDL/HDL label distribution ratio in SR-BI KO/CETP
Tg mice compared with SR-BI KO mice. This suggests that
human CETP, as anticipated, efficiently transports choles-
teryl esters from HDL to ApoB-containing (nonHDL) lipo-
proteins in SR-BI KO mice.
Compared with wild-type mice, adrenals from SR-BI KO
mice are darker due to an almost complete depletion of
lipid in the adrenal cortex as a result of the impaired adrenal
uptake of HDL-cholesteryl esters (5). Strikingly, macro-
scopically the adrenals of SR-BI KO/CETP Tg mice and
SR-BI KO mice are essentially identical and are significantly
different from those of wild-type mice. As can be appreci-
ated from the photograph depicted in Fig. 2A, both the
adrenals of SR-BI KO/CETP Tg and SR-BI KO are visually
darker (red color instead of white color) and have a larger
volume compared with those of wild-type mice. In agree-
ment, an overall higher weight of the adrenals was observed
(5.2 6 0.4 mg and 4.8 6 0.3 mg for SR-BI KO/CETP and
SR-BI KO mice vs. 3.4 6 0.2 mg for WT mice; P , 0.05 for
both; Fig. 2B). As the external phenotype of the adrenals in
SR-BI KO mice was not affected by the expression of CETP,
we determined the extent of lipid loading in the adrenal
cortex of the three different types of mice (Fig. 3). In accor-
dance with our previous findings (5), Oil redOneutral lipid
TABLE 2. Relative mRNA expression levels of SR-BI and CETP in different organs isolated from WT mice, SR-BI KO mice, and SR-BI KO mice
expressing human CETP (SR-BI KO/CETP Tg)
Liver Spleen Adrenal White Adipose Tissue
SR-BI CETP SR-BI CETP SR-BI CETP SR-BI CETP
WT 0.12 6 0.02 n.d. 0.018 6 0.001 n.d. 0.42 6 0.12 n.d. 0.029 6 0.015 n.d.
SR-BI KO n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
SR-BI KO/CETP Tg n.d. 0.14 6 0.13 n.d. 0.10 6 0.03 n.d. 0.012 6 0.002 n.d. 0.025 6 0.004
Values are relative to the housekeeping gene expression and represent means 6 SEM of three mice per group. n.d., not detectable.
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staining in the adrenal cortex was almost completely absent
in SR-BI KO mice compared with wild-type mice (Fig. 3A).
Furthermore, no remarkable change in Oil red O staining
was observed upon expression of CETP in SR-BI KO mice
(Fig. 3A) as only limited Oil red O staining could be seen
specifically in the zona glomerulosa (the mineralocorticoid
producing cells) but not the zona fasciculata (the glucocor-
ticoid producing cells) or zona reticularis (production of
androgens) of the adrenal cortex of both SR-BI KO/CETP
and control SR-BI KO mice. In contrast, all three zones of
the cortex stained positive for neutral lipid in the adrenals
of WT mice (Fig. 3A). Lipid analyses indicated that the ad-
renal cholesteryl ester content was not significantly different
between SR-BI KO (7.3 6 1.1 mg/mg protein) and SR-BI
KO/CETPTgmice (8.56 0.6mg/mgprotein) but was signif-
icantly lower (P , 0.001 for both) compared with wild-type
controls (16.5 6 1.4 mg/mg protein). Immunohistochem-
ical staining for CETP showed that the CETP protein is
specifically expressed in the zona glomerulosa within the cor-
tex of adrenals from SR-BI KO/CETP Tg mice (Fig. 3B).
Combined, these findings suggest that the transfer of HDL-
cholesteryl esters to ApoB-containing lipoproteins leading
to subsequent uptake via the LDL receptor does not signifi-
cantly contribute to cholesteryl ester storage in the adrenal
cortex, while the adrenal expression of human CETP is in-
sufficient to normalize cholesteryl ester storage.
Importantly, adrenocortical cells within the zona fascicu-
lata need cholesterol to produce glucocorticoid hormones,
such as cortisol in humans and corticosterone in rodents. As
the zona fasciculata of SR-BI KOmice with or without trans-
genic expression of CETP is equally depleted of lipid, we
determined the effect of CETP expression on plasma corti-
costerone levels. Under fed (nonstressed) conditions, no
significant change in the plasma corticosterone levels was
observed between the three different genotypes (Fig. 4).
In contrast, plasma corticosterone levels in SR-BI KO and
SR-BI KO/CETP Tg mice were significantly lower (P , 0.01
for both) compared with those of WT mice under conditions
of physiological stress induced by overnight fasting (Fig. 4).
Measurements of ACTH, a potent activator of adrenal cortex
growth and steroidogenesis (22), indicated that the impaired
Fig. 2. A: Photograph of adrenals fromWT, control SR-BI KOmice,
and SR-BI KOmice expressing human CETP (SR-BI KO/CETP Tg).
B: Weight of the adrenals from WT (white bars), SR-BI KO mice
(hatched bars), and SR-BI KO/CETP Tg mice (black bars). Values
are means 6 SEM (n 5 3). * P , 0.05 (one-way ANOVA).
Fig. 1. A: Plasma total cholesterol levels inWT(white bars), control SR-BI KOmice (hatched bars), and SR-BI KOmice expressing humanCETP
(SR-BI KO/CETP Tg; black bars). B) The adrenal uptake of HDL-cholesteryl ether (CEt) in WT (white bars), control SR-BI KO mice (hatched
bars), and SR-BI KOmice expressing humanCETP (SR-BI KO/CETPTg; black bars).Mice were injected intravenously with [3H]CEt-HDL, and
after 24 h the amount of radioactivity in the adrenals was determined. Values are expressed as percentage of the injected dose per gram tissue
(%ID/g) and are means 6 SEM (n 5 3). C: Distribution of [3H]CEt over the different lipoprotein fractions generated from pooled plasma
of three mice at 8 h after injection of the [3H]CEt-HDL in control SR-BI KOmice (hatched bars) and SR-BI KOmice expressing human CETP
(SR-BI KO/CETP Tg; black bars). * P , 0.05, ** P , 0.01, and *** P , 0.001 (one-way ANOVA).
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corticosterone response to fasting was not due to a decrease
in ACTH levels as SR-BI KO and SR-BI KO/CETP Tg mice
displayed a 2- to 3-fold increase (P, 0.05) in plasma ACTH
levels compared with WT controls under fasting conditions
(Fig. 5A). In addition, the mRNA expression of the LDL re-
ceptor, which is rapidly induced by ACTH in adrenocortical
cells both in vitro (13, 23) and in vivo (24), was stimulated
.3-fold (P , 0.01) in the adrenals of SR-BI KO mice and
SR-BI KO/CETP Tg mice, indicative for optimal ACTH sig-
naling in the adrenals of these animals (Fig. 5B). As CETP
expression does not normalize the corticosterone response
to fasting at a background of relatively high adrenal LDL re-
ceptor expression in SR-BI KO mice, it is suggested that
SR-BI KO/CETP Tgmice similarly to control SR-BI KOmice
also suffer from adrenal glucocorticoid insufficiency.
Recent studies by Cai et al. (6) have indicated that SR-BI
KO mice are more susceptible to LPS-induced septic shock
and death as a result of the adrenal glucocorticoid insuffi-
ciency. We did also observe a significantly (P , 0.001) en-
hanced response of the pro-inflammatory cytokine TNF-a
in SR-BI KOmice compared with wild-typemice upon injec-
tion of a sublethal dose of LPS (50 mg/kg) (Fig. 6A). Inter-
estingly, the peak value of the plasma TNF-a level at 60 min
after LPS injection (6.256 0.52 ng/ml for SR-BI KO/CETP
Tg and 6.236 0.03 ng/ml for SR-BI KOmice) and the total
TNF-a response in time (area-under-curve 553 vs. 573 ng/
ml·min, respectively) were identical between SR-BI KO/
CETP Tg and control SR-BI KO mice upon the challenge
with LPS (Fig. 6A). In addition, both SR-BI KO and SR-BI
KO/CETP Tg mice failed to induce plasma corticosterone
levels in response to LPS (Fig. 6B), which further establishes
that transgenic expression of CETP is not able to overcome
the adrenal glucocorticoid insufficiency in SR-BI KO mice.
DISCUSSION
SR-BI deficiency in mice leads to glucocorticoid insuffi-
ciency as a result of an impaired adrenal uptake of choles-
teryl esters fromHDL (4, 5).Within the adrenals, a constant
supply of cholesterol is required to serve as precursor for the
synthesis of mineralocorticoids and glucocorticoids (25).
The cholesterol needed for optimal steroid synthesis in
the adrenals can be acquired from 1) intracellular de novo
synthesis of free cholesterol by the enzyme HMG-CoA re-
ductase, 2) intracellular catabolism of stored cholesteryl
Fig. 3. A: Oil red O neutral lipid staining on cryo-
sections of adrenals from WT mice, SR-BI KO mice,
and SR-BI KO mice expressing human CETP (SR-BI
KO/CETP Tg). Sections were counterstained with
hematoxylin for nuclei. Note the clearly diminished
lipid staining in the adrenal cortex of SR-BI KO mice,
which is not reversed by expression of human CETP.
B: Immunohistochemical staining for CETP on adre-
nal sections from SR-BI KO/CETP Tgmice. CETP pro-
tein expression is localized specifically in the zona
glomerulosa of the adrenal cortex.
Fig. 4. Plasma corticosterone levels in WT (white
bars), control SR-BI KO mice (hatched bars) mice,
and SR-BI KO mice expressing human CETP (SR-
BI KO/CETP Tg; black bars) that were nonfasted
(FED) or subjected to 16 h of fasting (FASTED). Values
are means 6 SEM (n 5 4–15). Fasting induced a sig-
nificant rise in plasma corticosterone levels (P ,
0.001). ** P , 0.01 compared with fasted WT mice
(two-way ANOVA).
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esters to free cholesterol by neutral cholesteryl ester hydro-
lase, or 3) receptor-mediated uptake and subsequent intra-
cellular catabolism of cholesteryl esters from circulating
VLDL, LDL, and HDL particles [reviewed in Kraemer
(25)]. In addition to the “HDL receptor” SR-BI, adrenals ex-
press the LDL receptor, which is involved in the whole par-
ticle endocytosis of the ApoB-containing lipoproteins VLDL
and LDL (12). Importantly, the expression of SR-BI and the
LDL receptor and steroidogenesis are coordinately regu-
lated by activators of both glucocorticoid (dibutyryl cAMP
and ACTH) and mineralocorticoid (PMA) synthesis in
adrenocortical cells both in vitro and in vivo (24, 26–31),
leading to the generally accepted suggestion that the LDL
receptor may also contribute to adrenal steroid hormone
synthesis in vivo. However, it has never been experimentally
defined to what extent the LDL receptor indeed allows op-
timal adrenal hormone production, i.e., corticosterone pro-
duction. There are no patients with a deficiency of the
human ortholog of SR-BI called CLA-1 (CD36 and lyso-
somal integral membrane protein-II analogous-1) (31). In
the human situation, an improper functioning of CLA-1 is
expected to be compensated for by the presence of CETP, a
protein that redistributes cholesteryl esters from HDL to
ApoB-containing lipoproteins, including LDL, leading to
an alternative uptake route of cholesteryl esters by the adre-
nals. In our experiments, we confirm that expression of hu-
man CETP in SR-BI KOmice indeed leads to the transfer of
cholesteryl esters from the relatively large HDL particles to
ApoB-containing lipoproteins accessible for LDL receptor-
mediated internalization (32). As already anticipated, the
presence of CETP in SR-BI KOmice resulted in an increased
delivery of cholesteryl esters from HDL via ApoB-containing
lipoproteins to the adrenals. The enhanced delivery of cho-
lesteryl esters upon CETP expression, however, was not
associated with a reversal of the changes in adrenal mor-
phology or plasma corticosterone and ACTH levels asso-
ciated with SR-BI deficiency. Furthermore, no difference
was observed in the LPS-induced TNF-a response between
SR-BI KO mice with and without CETP expression. These
data show for the first time that the uptake of cholesteryl
Fig. 6. LPS-induced TNF-a response (A) and corticosterone response (B) in WT (open circles), control SR-BI KOmice (closed circles), and
SR-BI KO mice expressing human CETP (SR-BI KO/CETP Tg; closed triangles). Mice were injected intravenously with 50 mg/kg LPS. Values
are means6 SEM (n5 4–6). The TNF-a and corticosterone responses in SR-BI KO/CETP and SR-BI KO mice were essentially the same and
significantly different from those of WT mice (P , 0.001 for both; two-way ANOVA).
Fig. 5. Plasma ACTH levels (A) and adrenal relative
LDL receptor (LDLR)mRNA expression levels (B) in
WT (white bars), control SR-BI KO mice (hatched
bars), and SR-BI KO mice expressing human CETP
(SR-BI KO/CETP Tg; black bars) that were subjected
to 16 h of fasting. Values aremeans6 SEM(n5 3–14).
* P , 0.05 and ** P , 0.01 (one-way ANOVA).
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esters via other routes than SR-BI (i.e., via the LDL recep-
tor) is not sufficiently effective to generate the cholesterol
pool needed for optimal adrenal steroid hormone produc-
tion. In accordance with this, recent studies by Kraemer
et al. (33) using LDL receptor KO mice have indicated that
endocytic adrenal cholesterol uptake via the LDL receptor
is not necessary for ACTH- and dibutyryl cAMP-induced
maximal corticosterone production in vivo. Furthermore,
inhibition of SR-BI function in murine adrenocortical cells
in vitro induced a marked 70–80% decrease in selective
cholesteryl ester uptake and corticosterone secretion (34).
We now firmly establish that SR-BI-mediated uptake of
cholesteryl esters is the primary route for the delivery of
HDL-cholesterol to the steroidogenic pathway in vivo and
that LDL receptor-mediated uptake cannot compensate
for the absence of the SR-BI-mediated uptake route.
In conclusion, we have shown that under human-like
conditions, that is, in the presence of human CETP, the
transfer of cholesteryl esters from HDL to ApoB-containing
lipoproteins by CETP is not able to reverse the adrenal in-
sufficiency in SR-BI KO mice. Our findings suggest that the
adrenal uptake of HDL-cholesteryl esters via SR-BI probably
also contributes significantly to adrenal steroidogenesis in
humans. However, it should be acknowledged that the rela-
tive acceptor (i.e., LDL) availability for CETP-mediated
transfer of cholesteryl esters from HDL is much higher in
the human situation (high LDL and HDL levels) than in
our current SR-BI KO mouse model (high HDL and very
low LDL levels). An additional key point is that the higher
LDL levels in humans provide more substrate for the LDL
receptor-mediated uptake of LDL cholesterol by the adre-
nals. This is also why the results with LDL-poor mice should
be interpreted cautiously when extrapolating to humans.
It will therefore be important to study whether carriers
of polymorphisms in the human SR-BI (CLA-1) gene that
are associated with changes in HDL-cholesterol levels
(35–38) are indeedmore susceptible to adrenal insufficiency,
stress-related diseases (i.e., anxiety and depression), and/or
inflammatory diseases (i.e., sepsis, rheumatoid arthritis,
and atherosclerosis).
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